Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control-Reference-Cited by-同舟云学术

Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control

Published:2010-02 Issue:2 Volume:12 Page:105-114
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Christiansen J. S.,Liebl A.,Davidson J. A.,Ligthelm R. J.,Halimi S.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2009.01144.x/fullpdf

Reference42 articles.

1. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

2. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study;Stratton;BMJ,2000

3. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c);Monnier;Diabetes Care,2003

4. Postchallenge hyperglycemia in older adults is associated with increased cardiovascular risk profile;Crandall;J Clin Endocrinol Metab,2009

5. Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes;Bibra;Horm Metab Res,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetic patients with COVID-19 need more attention and better glycemic control;World Journal of Diabetes;2020-12-15

2. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as insulin starter in Chinese patients with type 2 diabetes mellitus (CLASSIFY study): Subgroup analysis of a Phase 4 open-label randomized trial;Journal of Diabetes;2016-09-26

3. Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study;Diabetic Medicine;2016-07-28

4. IDegAsp (insulin degludec + insulin aspart) for the management of type 2 diabetes: current status;Expert Review of Endocrinology & Metabolism;2016-02-26

5. Effect of a new insulin treatment regimen on glycaemic control and quality of life of Muslim patients with type 2 diabetes mellitus during Ramadan fast - an open label, controlled, multicentre, cluster randomised study;International Journal of Clinical Practice;2015-07-31